Forbes, Matthew Herper--There are two ways that a medicine can be removed from our New Drugs To Watch list. Data can convince us that the medicine’s chances are no longer good enough to meet our criteria, or the U.S. Food and Drug Administration can approve it, in which case it is no longer an experimental medicine and it graduates from our list.
